Daniela Slavin
About Daniela Slavin
Daniela Slavin is a Senior Clinical Development Scientist at Mirati Therapeutics, with extensive experience in clinical research and development. She has held various research positions at notable institutions, including GNF, Ligand Pharmaceuticals, and cCARE.
Current Role at Mirati Therapeutics
Daniela Slavin serves as a Senior Clinical Development Scientist at Mirati Therapeutics. She has been in this role since 2021, contributing her expertise in clinical development within the biotechnology sector. Her work focuses on advancing therapeutic solutions and enhancing clinical trial processes in San Diego, California.
Previous Experience in Clinical Research
Prior to her current position, Daniela Slavin worked as a Clinical Research Coordinator at cCARE - California Cancer Associates for Research & Excellence from 2015 to 2020. In this role, she managed clinical trials and coordinated research activities in the Greater San Diego Area. Her experience in clinical research has been pivotal in her career development.
Research Background
Daniela Slavin has a solid foundation in research, having worked at several prominent institutions. She was a Research Associate at the University of California, San Diego from 2003 to 2006 and later at The Scripps Research Institute from 2006 to 2008. These positions allowed her to deepen her research skills and knowledge in the life sciences.
Education and Expertise
Daniela Slavin earned her PhD in Biochemistry from Universidad Nacional de Córdoba, where she studied from 1996 to 2002. This academic background has equipped her with a strong understanding of biochemical processes, which she applies in her clinical development work.
Early Career Experience
Before her extensive work in clinical research, Daniela Slavin held positions as a Research Scientist at Ligand Pharmaceuticals from 2008 to 2010 and as a Scientist at GNF from 2012 to 2014. These roles contributed to her development as a scientist and provided her with valuable industry experience.